Balato, Anna
Ambrogio, Francesca
Burlando, Martina
Carrera, Carlo Giovanni
Chiricozzi, Andrea
Esposito, Maria
Piaserico, Stefano
Teoli, Miriam
Gisondi, Paolo http://orcid.org/0000-0002-1777-9001
Article History
Received: 24 October 2023
Accepted: 13 November 2023
First Online: 2 December 2023
Declarations
:
: This study was supported by BI. BI had no role in the design, analysis or interpretation of the results in this study. BI was given the opportunity to review the manuscript for medical and scientific accuracy, as well as intellectual property considerations. Maria Esposito served as speaker or board member for Abbvie, Amgen, Almirall, Eli Lilly, Janssen, Novartis, Sanofi, UCB. Stefano Piaserico has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Janssen, LEO Pharma, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Sandoz, and UCB. Francesca Ambrogio, Martina Burlando, Carlo Giovanni Carrera, Andrea Chiricozzi, Miriam Teoli and Paolo Gisondi have nothing to disclose.
: Ethical approval is not applicable to this article as no datasets were generated or analyzed during the current study. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.